GlaxoSmithKline disagrees with FDA decision regarding Advair

Email this article to a friend

Printable Version

GlaxoSmithKline PLC disagrees with the FDA's decision to label Advair, an asthma drug made by GSK, as a last option for those asthma patients who have failed to respond to other options.

Share

About the author: Mike Adams is a holistic nutritionist with a passion for sharing empowering information to help improve personal and planetary health He has authored more than 1,500 articles and dozens of reports, guides and interviews on natural health topics, impacting the lives of millions of readers around the world who are experiencing phenomenal health benefits from reading his articles. Adams is a trusted, independent journalist who receives no money or promotional fees whatsoever to write about other companies' products. In 2007, Adams launched EcoLEDs, a maker of energy efficient LED lights that greatly reduce CO2 emissions. He also launched an online retailer of environmentally-friendly products (BetterLifeGoods.com) and uses a portion of its profits to help fund non-profit endeavors. He's also the founder and CEO of a well known email mail merge software developer whose software, 'Email Marketing Director,' currently runs the NaturalNews email subscriptions. Adams volunteers his time to serve as the executive director of the Consumer Wellness Center, a 501(c)3 non-profit organization, and practices nature photography, Capoeira, Pilates and organic gardening.


Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • National Paxil Protest invites antidepressant drugs victims to join public outcry against GlaxoSmithKline • GlaxoSmithKline settles price fraud lawsuit with 40 states • Bipolar drug Lamictal tied to birth defects when used by expectant mothers	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/015470_GlaxoSmithKline_asthma_labeling.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/015470_GlaxoSmithKline_asthma_labeling.html">GlaxoSmithKline disagrees with FDA decision regarding Advair</a>